Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Petróleo Brasileiro SA (PBR) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Petróleo Brasileiro SATrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Petróleo Brasileiro SA vs Health Care Select Sector SPDR Fund — how do they compare? Petróleo Brasileiro SA trades at $18.92 (market cap $112.59B), while Health Care Select Sector SPDR Fund trades at $159.56. The key difference: Petróleo Brasileiro SA pays a 9.51% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Petróleo Brasileiro SA nearer its low. Which is the better fit depends on your goals.

PBRXLV
Market Cap
$112.59B
Sector
Technology
52-Week High
$22.03$164.48
52-Week Low
$11.54$129.01
Enterprise Value
$176.05B
Dividend Yield
9.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Petróleo Brasileiro SA

PBR trades at $18.19, up 1.22% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 5.73 and robust profitability, including a 21.47% net income margin. Recent news highlights expansion in deepwater operations and strategic partnerships, while earnings have mostly beaten expectations except for a Q1 2026 miss.

The outlook is positive, supported by attractive valuation, solid cash flows, and dividend payments. Risks include oil price volatility and execution of new projects. Analyst consensus leans bullish with 50% buy ratings, but overbought RSI levels suggest near-term caution.

Health Care Select Sector SPDR Fund

XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.

XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Petróleo Brasileiro SA

Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.

Read more on PBR

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV